Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Bullock

Showing results (151-160 of 220) with videos related to

Pageof 22
Sort By:
European Journal of Medicinal Chemistry|June 8, 2020
Receptor-interacting protein kinase 2 (RIPK2) and nucleotide-binding oligomerization domain (NOD) cell signaling inhibitors based on a 3,5-diphenyl-2-aminopyridine scaffoldChalada Suebsuwong, Bing Dai, Daniel M Pinkas, et al.
Molecules (Basel, Switzerland)|July 24, 2021
Crystal Structure-Guided Design of Bisubstrate Inhibitors and Photoluminescent Probes for Protein Kinases of the PIM FamilyOlivier E Nonga, Darja Lavogina, Erki Enkvist, et al.
Journal of Medicinal Chemistry|October 17, 2024
Structure-Guided Conformational Restriction Leading to High-Affinity, Selective, and Cell-Active Tetrahydroisoquinoline-Based Noncovalent Keap1-Nrf2 InhibitorsYuting Qin, Cecilie Poulsen, Dilip Narayanan, et al.
Cancer Chemotherapy and Pharmacology|January 29, 1999
Multiple DNA repair mechanisms and alkylator resistance in the human medulloblastoma cell line D-283 Med (4-HCR)Q Dong, S P Johnson, O M Colvin, et al.
Oncoimmunology|October 6, 2018
Formation and phenotypic characterization of CD49a, CD49b and CD103 expressing CD8 T cell populations in human metastatic melanomaMarit M Melssen, Walter Olson, Nolan A Wages, et al.
Structure (London, England : 1993)|March 13, 2009
Kinase domain insertions define distinct roles of CLK kinases in SR protein phosphorylationAlex N Bullock, Sanjan Das, Judit E Debreczeni, et al.
Journal of Medicinal Chemistry|July 17, 2019
2-Amino-2,3-dihydro-1<i>H</i>-indene-5-carboxamide-Based Discoidin Domain Receptor 1 (DDR1) Inhibitors: Design, Synthesis, and in Vivo Antipancreatic Cancer EfficacyDongsheng Zhu, Huocong Huang, Daniel M Pinkas, et al.
ACS Medicinal Chemistry Letters|March 25, 2017
Tetrahydroisoquinoline-7-carboxamide Derivatives as New Selective Discoidin Domain Receptor 1 (DDR1) InhibitorsZhen Wang, Yali Zhang, Sergio G Bartual, et al.
Oncotarget|March 7, 2018
Evaluation of SAS1B as a target for antibody-drug conjugate therapy in the treatment of pancreatic cancerKiley A Knapp, Eusebio S Pires, Sara J Adair, et al.
Plos One|May 7, 2013
A new class of small molecule inhibitor of BMP signalingCaroline E Sanvitale, Georgina Kerr, Apirat Chaikuad, et al.
Pageof 22

Showing results (151-160 of 220) with videos related to

Sort By:
Pageof 22
European Journal of Medicinal Chemistry|June 8, 2020
Receptor-interacting protein kinase 2 (RIPK2) and nucleotide-binding oligomerization domain (NOD) cell signaling inhibitors based on a 3,5-diphenyl-2-aminopyridine scaffoldChalada Suebsuwong, Bing Dai, Daniel M Pinkas, et al.
Molecules (Basel, Switzerland)|July 24, 2021
Crystal Structure-Guided Design of Bisubstrate Inhibitors and Photoluminescent Probes for Protein Kinases of the PIM FamilyOlivier E Nonga, Darja Lavogina, Erki Enkvist, et al.
Journal of Medicinal Chemistry|October 17, 2024
Structure-Guided Conformational Restriction Leading to High-Affinity, Selective, and Cell-Active Tetrahydroisoquinoline-Based Noncovalent Keap1-Nrf2 InhibitorsYuting Qin, Cecilie Poulsen, Dilip Narayanan, et al.
Cancer Chemotherapy and Pharmacology|January 29, 1999
Multiple DNA repair mechanisms and alkylator resistance in the human medulloblastoma cell line D-283 Med (4-HCR)Q Dong, S P Johnson, O M Colvin, et al.
Oncoimmunology|October 6, 2018
Formation and phenotypic characterization of CD49a, CD49b and CD103 expressing CD8 T cell populations in human metastatic melanomaMarit M Melssen, Walter Olson, Nolan A Wages, et al.
Structure (London, England : 1993)|March 13, 2009
Kinase domain insertions define distinct roles of CLK kinases in SR protein phosphorylationAlex N Bullock, Sanjan Das, Judit E Debreczeni, et al.
Journal of Medicinal Chemistry|July 17, 2019
2-Amino-2,3-dihydro-1<i>H</i>-indene-5-carboxamide-Based Discoidin Domain Receptor 1 (DDR1) Inhibitors: Design, Synthesis, and in Vivo Antipancreatic Cancer EfficacyDongsheng Zhu, Huocong Huang, Daniel M Pinkas, et al.
ACS Medicinal Chemistry Letters|March 25, 2017
Tetrahydroisoquinoline-7-carboxamide Derivatives as New Selective Discoidin Domain Receptor 1 (DDR1) InhibitorsZhen Wang, Yali Zhang, Sergio G Bartual, et al.
Oncotarget|March 7, 2018
Evaluation of SAS1B as a target for antibody-drug conjugate therapy in the treatment of pancreatic cancerKiley A Knapp, Eusebio S Pires, Sara J Adair, et al.
Plos One|May 7, 2013
A new class of small molecule inhibitor of BMP signalingCaroline E Sanvitale, Georgina Kerr, Apirat Chaikuad, et al.
Pageof 22